{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:55:43Z","timestamp":1790283343871,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["MDA516161"],"award-info":[{"award-number":["MDA516161"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR071649"],"award-info":[{"award-number":["R01AR071649"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.actbio.2020.10.009","type":"journal-article","created":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T10:09:24Z","timestamp":1602410964000},"page":"196-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Polymeric nanoparticles functionalized with muscle-homing peptides for targeted delivery of phosphatase and tensin homolog inhibitor to skeletal muscle"],"prefix":"10.1016","volume":"118","author":[{"given":"Di","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihuan","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2020.10.009_bib0001","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrg3460","article-title":"Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches","volume":"14","author":"Fairclough","year":"2013","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.actbio.2020.10.009_bib0002","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1083\/jcb.122.4.809","article-title":"A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin","volume":"122","author":"Ervasti","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.actbio.2020.10.009_bib0003","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0092-8674(91)90035-W","article-title":"Membrane organization of the dystrophin-glycoprotein complex","volume":"66","author":"Ervasti","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.actbio.2020.10.009_bib0004","first-page":"457","article-title":"Dystrophin: the protein product of the Duchene muscular dystrophy locus. 1987","volume":"24","author":"Hoffman","year":"1992","journal-title":"Biotechnology"},{"key":"10.1016\/j.actbio.2020.10.009_bib0005","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/338259a0","article-title":"Association of dystrophin and an integral membrane glycoprotein","volume":"338","author":"Campbell","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2020.10.009_bib0006","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1093\/hmg\/ddr362","article-title":"Elevated levels of active matrix metalloproteinase-9 cause hypertrophy in skeletal muscle of normal and dystrophin-deficient mdx mice","volume":"20","author":"Dahiya","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.actbio.2020.10.009_bib0007","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1083\/jcb.200108071","article-title":"Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice","volume":"157","author":"Barton","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.actbio.2020.10.009_bib0008","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1113\/expphysiol.2008.042838","article-title":"Insulin-like growth factor-I analogue protects muscles of dystrophic mdx mice from contraction-mediated damage","volume":"93","author":"Gehrig","year":"2008","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.actbio.2020.10.009_bib0009","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/mus.25752","article-title":"Osteopontin is linked with AKT, FoxO1, and myostatin in skeletal muscle cells","volume":"56","author":"Nghiem","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.actbio.2020.10.009_bib0010","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/ana.10385","article-title":"Loss of myostatin attenuates severity of muscular dystrophy in mdx mice","volume":"52","author":"Wagner","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.actbio.2020.10.009_bib0011","doi-asserted-by":"crossref","first-page":"13375","DOI":"10.1074\/jbc.273.22.13375","article-title":"The tumor suppressor, PTEN\/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate","volume":"273","author":"Maehama","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actbio.2020.10.009_bib0012","doi-asserted-by":"crossref","first-page":"15000","DOI":"10.1073\/pnas.192571199","article-title":"Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle","volume":"99","author":"Haslett","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.actbio.2020.10.009_bib0013","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2353\/ajpath.2009.080460","article-title":"PTEN contributes to profound PI3K\/Akt signaling pathway deregulation in dystrophin-deficient dog muscle","volume":"174","author":"Feron","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.actbio.2020.10.009_bib0014","article-title":"PTEN inhibition ameliorates muscle degeneration and improves muscle function in a mouse model of Duchenne muscular dystrophy","author":"Yue","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.actbio.2020.10.009_bib0015","series-title":"Vanadium Compounds: Biochemical and Therapeutic Applications","author":"Srivastava","year":"1996"},{"key":"10.1016\/j.actbio.2020.10.009_bib0016","doi-asserted-by":"crossref","first-page":"18741","DOI":"10.1021\/acsami.6b06889","article-title":"Nanotherapeutics of PTEN inhibitor with mesoporous silica nanocarrier effective for axonal outgrowth of adult neurons","volume":"8","author":"Kim","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.actbio.2020.10.009_bib0017","first-page":"5","article-title":"Drug delivery and targeting","author":"Langer","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2020.10.009_bib0018","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2020.10.009_bib0019","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1021\/mp200470c","article-title":"Effect of PEGylation on protein hydrodynamics","volume":"9","author":"Gokarn","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2020.10.009_bib0020","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1039\/c2cs15344k","article-title":"Targeted polymeric therapeutic nanoparticles: Design, development and clinical translation","volume":"41","author":"Kamaly","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.actbio.2020.10.009_bib0021","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","article-title":"Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology","volume":"66","author":"Bertrand","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2020.10.009_bib0022","doi-asserted-by":"crossref","first-page":"11449","DOI":"10.1073\/pnas.1411393111","article-title":"Correlating animal and human phase Ia\/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA","volume":"111","author":"Zuckerman","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.actbio.2020.10.009_bib0023","doi-asserted-by":"crossref","first-page":"128ra39","DOI":"10.1126\/scitranslmed.3003651","article-title":"Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile","volume":"4","author":"Hrkach","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.actbio.2020.10.009_bib0024","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/mt.2014.63","article-title":"Effective dystrophin restoration by a novel muscle-homing peptide-morpholino conjugate in dystrophin-deficient mdx mice","volume":"22","author":"Gao","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2020.10.009_bib0025","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1038\/mtna.2016.46","article-title":"Fructose promotes uptake and activity of oligonucleotides with different chemistries in a context-dependent manner in mdx mice","volume":"5","author":"Cao","year":"2016","journal-title":"Mol. Ther. - Nucleic Acids."},{"key":"10.1016\/j.actbio.2020.10.009_bib0026","doi-asserted-by":"crossref","first-page":"eaat0195","DOI":"10.1126\/scitranslmed.aat0195","article-title":"Anchor peptide captures, targets, and loads exosomes of diverse origins for diagnostics and therapy","volume":"10","author":"Gao","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.actbio.2020.10.009_bib0027","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.celrep.2016.11.002","article-title":"Conditional loss of Pten in myogenic progenitors leads to postnatal skeletal muscle hypertrophy but age-dependent exhaustion of satellite cells","volume":"17","author":"Yue","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.actbio.2020.10.009_bib0028","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s11940-018-0513-6","article-title":"Current and emerging therapies for Duchenne muscular dystrophy","volume":"20","author":"Crone","year":"2018","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.actbio.2020.10.009_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113086","article-title":"Stem cell-based therapies for Duchenne muscular dystrophy","volume":"323","author":"Sun","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.actbio.2020.10.009_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/nat.2016.0657","article-title":"FDA approves Eteplirsen for Duchenne muscular dystrophy: the next chapter in the eteplirsen saga","volume":"27","author":"Aartsma-Rus","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.actbio.2020.10.009_bib0031","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0168-3659(01)00218-8","article-title":"PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats","volume":"71","author":"Li","year":"2001","journal-title":"J. Control. Release."},{"key":"10.1016\/j.actbio.2020.10.009_bib0032","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1359-6446(03)02988-X","article-title":"Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress","volume":"9","author":"Marcucci","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.actbio.2020.10.009_bib0033","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1087250","article-title":"Design of nanoparticle-based carriers for targeted drug delivery","volume":"2016","author":"Yu","year":"2016","journal-title":"J. Nanomater."},{"key":"10.1016\/j.actbio.2020.10.009_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/npjregenmed.2016.6","article-title":"Targeting muscle stem cell intrinsic defects to treat Duchenne muscular dystrophy","volume":"1","author":"Dumont","year":"2016","journal-title":"Npj Regen. Med."},{"key":"10.1016\/j.actbio.2020.10.009_bib0035","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1093\/hmg\/ddp395","article-title":"A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice","volume":"18","author":"Yin","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.actbio.2020.10.009_bib0036","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.peptides.2010.06.036","article-title":"Identification of a novel muscle targeting peptide in mdx mice","volume":"31","author":"Seow","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.actbio.2020.10.009_bib0037","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/nmat4718","article-title":"Mechanism of hard-nanomaterial clearance by the liver","volume":"15","author":"Tsoi","year":"2016","journal-title":"Nat. Mater."},{"key":"10.1016\/j.actbio.2020.10.009_bib0038","doi-asserted-by":"crossref","first-page":"14038","DOI":"10.1038\/mtm.2014.38","article-title":"Adeno-associated viral vectors do not efficiently target muscle satellite cells","volume":"1","author":"Arnett","year":"2014","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"10.1016\/j.actbio.2020.10.009_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms14328","article-title":"Pten is necessary for the quiescence and maintenance of adult muscle stem cells","volume":"8","author":"Yue","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2020.10.009_bib0040","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nm.4062","article-title":"PTEN opposes negative selection and enables oncogenic transformation of pre-B cells","volume":"22","author":"Shojaee","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2020.10.009_bib0041","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1023\/B:PHAM.0000029293.89113.d5","article-title":"The permeability and cytotoxicity of insulin-mimetic vanadium compounds","volume":"21","author":"Yang","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actbio.2020.10.009_bib0042","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ncb1101-1014","article-title":"Akt\/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo","volume":"3","author":"Bodine","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.actbio.2020.10.009_bib0043","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1172\/JCI73579","article-title":"MicroRNA-486-dependent modulation of DOCK3\/PTEN\/AKT signaling pathways improves muscular dystrophy-associated symptoms","volume":"124","author":"Alexander","year":"2014","journal-title":"J. Clin. Invest."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706120305985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706120305985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:30:55Z","timestamp":1761672655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706120305985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":43,"alternative-id":["S1742706120305985"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2020.10.009","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymeric nanoparticles functionalized with muscle-homing peptides for targeted delivery of phosphatase and tensin homolog inhibitor to skeletal muscle","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2020.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}